| Owner | Title | From | %Ownership |
|---|---|---|---|
| Bardon, Christiana, Goh | Managing Member | 06/2010 | > 75% |
| Crispen, Jeff, William | Chief Financial Officer, Chief Compliance Officer | 03/2020 | < 5% |
| Fund structure | AUM | Fund type |
|---|---|---|
| Bioimpact Capital LLC | $1.99 bn | |
| Bioimpact Equities Fund, LP | $92.93 mm | Hedge Fund |
| Bioimpact Equities Master Fund, LP | $45.35 mm | Hedge Fund |
| Bioimpact Equities Offshore Fund, LTD. | ||
| Oncology Impact Fund 2, L.P. | $855.81 mm | Other Private Fund |
| Oncology Impact Private Investment Fund 2, L.P. | ||
| Oncology Impact Public Investment Fund 2, L.P. | ||
| Ubs Oncology Impact Fund L.P. | $992.57 mm | Other Private Fund |
| Ubs Oncology Impact Fund (Cayman) Investor L.P. | ||
| Ubs Oncology Impact Fund (Cayman) Investor LTD. |
